Filing Details
- Accession Number:
- 0001209191-15-007510
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-29 17:34:55
- Reporting Period:
- 2015-01-27
- Filing Date:
- 2015-01-29
- Accepted Time:
- 2015-01-29 17:34:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1311210 | Patrick Clarence Machado | C/O Medivation, Inc. 525 Market St., 36Th Floor San Francisco CA 94105 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-01-27 | 7,294 | $10.59 | 38,794 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-01-27 | 28,706 | $9.39 | 67,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-01-27 | 17,200 | $104.93 | 50,300 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-01-27 | 18,800 | $105.67 | 31,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-01-27 | 7,294 | $0.00 | 7,294 | $10.59 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-01-27 | 28,706 | $0.00 | 28,706 | $9.39 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-09-30 | No | 4 | M | Direct | |
107,990 | 2018-10-30 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices between $104.375 and $105.37. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices between $105.38 and $106.23. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.